Despite new medication, cystic fibrosis often leads to permanent lung damage. Working with an international team, researchers from the Technical University of Munich (TUM) have discovered that the ...

The biotech is evaluating several cystic fibrosis medicines that could either work alongside Vertex’s top-selling Trikafta or ...

A study led by TUM researchers finds that cystic fibrosis alters immune cells early in life, likely before birth. These ...

Despite new medication, cystic fibrosis often leads to permanent lung damage. Working with an international team, researchers from the Technical ...

Despite new medication, cystic fibrosis often leads to permanent lung damage. Working with an international team, researchers ...

Despite new medication, cystic fibrosis often leads to permanent lung damage. Working with an international team, researchers from the Technical University of Munich (TUM) have discovered that the ...

When my son was diagnosed with cystic fibrosis, I was taught everything I needed to know about CF…except how to navigate the anxiety he experiences. As he’s gotten older, I’ve struggled to know how to ...

By the time Enid Katz was two years old, she had already suffered through several bouts of bronchitis and was always hungry, ...

When cystic fibrosis hits your lungs hard, hit back. Everything you need to know about getting your lungs back into shape is ...

Sionna is working on a medicines it claims can challenge Vertex Pharmaceuticals’ dominant cystic fibrosis business. The company designed its therapies to stabilize a tough-to-drug region of the CFTR ...

ARCT-810 is under clinical development by Arcturus Therapeutics and currently in Phase II for Ornithine-Transcarbamylase Deficiency. According to GlobalData, Phase II drugs for ...

Cystic fibrosis is an inherited, life-threatening disorder that affects multiple organs and is caused by a defective gene that leads to the production of thickened mucus, which clogs airways and the ...